Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
		
    Phenotypes of prediabetes and stratification of cardiometabolic risk.
        
        Lancet Diabet. Endocrinol. 4, 789-798 (2016)
    
    
    
				Prediabetes is associated with increased risks of type 2 diabetes, cardiovascular disease, dementia, and cancer, and its prevalence is increasing worldwide. Lifestyle and pharmacological interventions in people with prediabetes can prevent the development of diabetes and possibly cardiovascular disease. However, prediabetes is a highly heterogeneous metabolic state, both with respect to its pathogenesis and prediction of disease. Improved understanding of these features and precise phenotyping of prediabetes could help to improve stratification of disease risk. In this Personal View, we focus on the extreme metabolic phenotypes of metabolically healthy obesity and metabolically unhealthy normal weight, insulin secretion failure, insulin resistance, visceral obesity, and non-alcoholic fatty liver disease. We present new analyses aimed at improving characterisation of phenotypes in lean, overweight, and obese people with prediabetes. We discuss evidence from lifestyle intervention studies to explore whether these phenotypes can also be used for individualised prediction and prevention of cardiometabolic diseases.
			
			
		Impact Factor
					Scopus SNIP
					Web of Science
Times Cited
					Times Cited
Scopus
Cited By
					
					Cited By
Altmetric
					
				16.320
					4.364
					111
					125
					
					
				Anmerkungen
				
					
						 
						
					
				
			
				
			
				Besondere Publikation
				
					
						 
					
				
			
			
			
				Auf Hompepage verbergern
				
					
						 
					
				
			
			
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
     
    
    
        Schlagwörter
        Impaired Glucose-tolerance; Life-style Intervention; Type-2 Diabetes-mellitus; Fatty Liver-disease; Insulin Secretory Dysfunction; Whitehall Ii Cohort; Post-hoc Analysis; Metabolically Healthy; Cardiovascular-disease; Follow-up
    
 
     
    
    
        Sprache
        
    
 
    
        Veröffentlichungsjahr
        2016
    
 
     
    
        HGF-Berichtsjahr
        2016
    
 
    
    
        ISSN (print) / ISBN
        2213-8587
    
 
    
        e-ISSN
        2213-8595
    
 
     
     
     
	     
	 
	 
    
        Zeitschrift
        Lancet Diabetes and Endocrinology
    
 
		
    
        Quellenangaben
        
	    Band: 4,  
	    Heft: 9,  
	    Seiten: 789-798 
	    
	    
	
    
 
  
         
        
            Verlag
            Elsevier
        
 
        
            Verlagsort
            New York
        
 
	
         
         
         
         
         
	
         
         
         
    
         
         
         
         
         
         
         
    
        Begutachtungsstatus
        Peer reviewed
    
 
     
    
        POF Topic(s)
        90000 - German Center for Diabetes Research
    
 
    
        Forschungsfeld(er)
        Helmholtz Diabetes Center
    
 
    
        PSP-Element(e)
        G-502400-002
G-502400-001
 
     
     	
    
    G-502400-001
        WOS ID
        WOS:000385844300028
    
    
        PubMed ID
        27185609
    
    
        Erfassungsdatum
        2016-05-20